LB-101

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLB-101
Drug Alias NameLB-100 series (Lifelike Biomatic)Ionokinesdual ion channel modulators (Lifelike Biomatic)LB-101
ClassificationSmall molecules
Mechanisms of ActionIon channels modulators
TargetsIon channels
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLifelike Biomatic Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifelike Biomatic Inc
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A